Webinar: How Data and Information Present as Risks and Opportunities in Biotechs
In a fast-growing biotech, how does data and information present as a risk and opportunity? To tackle this question, Chris Jennings moderated a panel discussion with biotech industry experts Jackie Fernandes, Jennifer Heckman and Anthony Murabito.
Chris Jennings
Founding Partner
Watch panelists Jackie Fernandes, Jen Heckman and Anthony Murabito share data triumphs and lessons learned throughout their extensive careers while quickly moving from R&D through commercialization. (1:03:04)
In a fast-growing biotech, how does information pose as a risk and opportunity? - YouTube
In a fast-growing biotech, how does information pose as a risk and opportunity? Triverus Consulting
The following articles provide snapshots of the topics discussed:
- Data Changes from R&D, Preclinical, Clinical and Beyond
- Data Success Stories in the Biotech Industry
- Avoiding and Mitigating Common Data Risks in Biotechs
- Tackling Portfolio Expansion Hurdles in Life Sciences
- Balancing Data Transparency with Privacy and Security
Founding Partner
About \
Chris Jennings
Chris is an IT services Industry executive with over 19 years in the industry.
Featured articles
CRM for Emerging Biotechs: A Future-Ready Guide
The Boston Globe ranks Triverus on its 2025 Top Places to Work list
Triverus Named to Boston Business Journal’s 2025 Best Places to Work List